Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)
Status:
Completed
Trial end date:
2010-04-14
Target enrollment:
Participant gender:
Summary
This study will determine whether the plasma concentration-time profile and pharmacokinetics
(PK) of suvorexant (MK-4305) in participants with moderate and mild hepatic insufficiency are
similar to those observed in healthy participants.